Skip to main content
ACR Convergence 2025 Main banner
Final Program


Schedule at a Glance
Legend
Presentation Icons
CME
CME
Non-CME
Non-CME
In Person
In Person
On Demand
On Demand
Live Stream
Live Stream
Active Learning
Active Learning
Choose Rheum
Choose Rheum
Emerging Investigator Awardee
Emerging Investigator Awardee

  1. Home

  • Sunday, Oct 26th
    10:30 AM - 11:30 AM Central Time
    26S20: Immune-Metabolite Axis: How Microbial and Host Byproducts Drive Inflammation
    Location: W192A-C
    Moderator: Monica Guma, MD, PhD – UCSD
    Moderator: Andras Perl, MD, PhD – SUNY
    Session Coordinator: Caroline Jefferies, PhD – Cedars-Sinai Medical Center
     CE: 1.00
  • Sunday, Oct 26th
    10:30 AM - 11:00 AM Central Time
    Microbioal Metabolite That Regulates Sepsis
    Location: W192A-C
    Speaker: Robert Keskey, MD, PhD – University of Louisville
  • Sunday, Oct 26th
    11:00 AM - 11:30 AM Central Time
    Therapeutic Approaches to Treat Rheumatoid Arthritis Using Short-Chain Fatty Acids
    Location: W192A-C
    Speaker: Renuka Nayak, MD, PhD – University of California, San Francisco (UCSF)
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    Infection-related Rheumatic Disease Poster
    Location: Hall F1
     CE: 0.00
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0199: Pain Phenotypes and Social Determinants of Health in Chronic Chikungunya Arthritis: A Cross-Sectional Study
    Location: Hall F1
    Abstract Poster Presenter: Abebawork Adem, MD, MPH (she/her/hers) – George Washington University
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0200: Severe infections and malignancies in patients with cranial and extracranial giant cell arteritis treated with tocilizumab. National multicenter study of 471 patients of clinical practice
    Location: Hall F1
    Abstract Poster Presenter: Adrián Martín-Gutiérrez, -None- – Hospital Universitario Marques de Valdecilla, IDIVAL
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0201: Real-World study of immunogenicity and safety of the adjuvant recombinant vaccine against varicella zoster virus in patients with immune-mediated inflammatory diseases treated with Janus Kinase Inhibitors in comparison with healthy individuals
    Location: Hall F1
    Abstract Poster Presenter: Ana Victoria Esteban Vázquez, -None- – Sistema Nacional de Salud
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0202: Saudi Society for Rheumatology Consensus Recommendation on Vaccination Strategies in Adults Saudi with Autoimmune Rheumatic Disorders
    Location: Hall F1
    Abstract Poster Presenter: Fahidah Alenzi, MD – Princess Nourah bint Abdulrahman University
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0203: Risk Factors for Cytomegalovirus Infection in Patients Receiving Prolonged High-Dose Corticosteroids for Rheumatic Diseases: A Retrospective Cohort Study
    Location: Hall F1
    Abstract Poster Presenter: HEE WON CHO, MD (she/her/hers) – Seoul National University
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0204: Immunogenicity and safety summary for the chikungunya virus-like particle vaccine development programme
    Location: Hall F1
    Abstract Poster Presenter: Krystal Valenzuela, PhD – Bavarian Nordic
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0205: Implementation of the Varicella Zoster virus vaccine and its Real-World effectiveness
    Location: Hall F1
    Abstract Poster Presenter: Laura Mas Sanchez, MD – Hospital Universitari i Politecnic La Fe
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0206: Prospective Controlled Study of Humoral Response to Recombinant Zoster Vaccine in Cyclophosphamide-Treated Autoimmune Rheumatic Disease Patients: No Additional Impairment Compared to Other Immunosuppressive Therapies
    Location: Hall F1
    Abstract Poster Presenter: Nadia Emi Aikawa, MD, PhD (she/her/hers) – Rheumatology Division, University of Sao Paulo
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0207: The Feasibility and Clinical Effects of Anti-Inflammatory Diet Intervention In Patients Diagnosed With Long COVID (Post-Acute Sequelae of SARS CoV-2, PASC)
    Location: Hall F1
    Abstract Poster Presenter: Susan Lee, MD (she/her/hers) – UCSD
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0208: Current practices and challenges in tuberculosis screening and preventive treatment among patients with rheumatic diseases: A multiregional physician survey in China
    Location: Hall F1
    Abstract Poster Presenter: Xu Wang, PhD – Peking Union Medical College Hospital
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0209: A Retrospective Safety Analysis Based on Platelets in Arthrocentesis and Joint Injections in Cancer Patients
    Location: Hall F1
    Abstract Poster Presenter: Yuanteng Li, MD, RhMSUS – MD Anderson Cancer Center
  • Tuesday, Oct 28th
    1:00 PM - 2:30 PM Central Time
    28T35: Abstracts: Infection-related Rheumatic Disease
    Location: W190A-B
    Abstract Moderator: Dimitrios Vassilopoulos, MD – Clinical Immunology-Rheumatology Unit, 2nd Department of Internal Medicine and Laboratory, National and Kapodistrian University of Athens, School of Medicine, Hippokration General Hospital
    Abstract Moderator: Tamiko Katsumoto, MD, FACR – Stanford University
     CE: 0.00
  • Tuesday, Oct 28th
    1:00 PM - 1:15 PM Central Time
    2573: Impaired Humoral Response to Recombinant Herpes Zoster Vaccine in Rituximab Treated Autoimmune Rheumatic Diseases Patients: A Prospective Controlled Phase 4 Study
    Location: W190A-B
    Presenting Author: Nadia Emi Aikawa, MD, PhD (she/her/hers) – Rheumatology Division, University of Sao Paulo
  • Tuesday, Oct 28th
    1:15 PM - 1:30 PM Central Time
    2574: Differences in SARS-CoV-2 Antigen Persistence in Individuals with Systemic Autoimmune Rheumatic Diseases Compared to the General Population
    Location: W190A-B
    Presenting Author: Naomi Patel, MD, MPH – Massachusetts General Hospital
  • Tuesday, Oct 28th
    1:30 PM - 1:45 PM Central Time
    2575: Influenza and COVID-19 Vaccination Uptake Among Women with Systemic Rheumatic Diseases in New York City Assessed Between 2022 and 2024
    Location: W190A-B
    Presenting Author: Yongjay Kim, BA – Cornell University
  • Tuesday, Oct 28th
    1:45 PM - 2:00 PM Central Time
    2576: Methotrexate Treatment of Arthritis Caused by Chikungunya Virus (MARCH) Study: Anti-inflammatory cytokine signals related to decreased arthritis disease activity over time
    Location: W190A-B
    Presenting Author: Alfonso Sucerquia, MD, -None- – The George Washington University
  • Tuesday, Oct 28th
    2:00 PM - 2:15 PM Central Time
    2577: Duration of SARS-CoV-2 Viral Shedding After Acute Infection in Patients with Rheumatic Diseases Using B Cell Depletion or Tumor Necrosis Factor Inhibitors
    Location: W190A-B
    Presenting Author: Liya Sisay Getachew, MPH – Brigham and Women's Hospital
  • Tuesday, Oct 28th
    2:15 PM - 2:30 PM Central Time
    2578: Association of Oral Outpatient Antiviral Medications for COVID-19 with the Risk of Post-acute Sequelae of COVID-19 in Individuals with Systemic Autoimmune Rheumatic Diseases
    Location: W190A-B
    Presenting Author: Naomi Patel, MD, MPH – Massachusetts General Hospital